Inventor · disambiguated record
Nicolas Floch
Also filed as: FLOCH NICOLAS
0 granted patents·3 pending applications·0 citations·filing 2020–2023
Files withASTRAZENECA AB3
Top patents by PatentIndex Score
3 records- 0164US2025205233A1Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors in combination with an akt inhibitor for the treatment of cancerASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0254US2023056604A1Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancerASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 0352US2021161897A1Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancerASTRAZENECA AB·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Floch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →